Alpha Cubed Investments’s Cymabay Therapeutics CBAY Stock Holding History

Alpha Cubed Investments’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-20,000	Closed	-$115K	–	244
2017 Q2	$115K	Hold	20,000	–	–	0.02%	203
2017 Q1	$86K	Hold	20,000	–	–	0.02%	186
2016 Q4	$35K	Hold	20,000	–	–	0.01%	187
2016 Q3	$39K	Hold	20,000	–	–	0.01%	176
2016 Q2	$35K	Hold	20,000	–	–	0.01%	144
2016 Q1	$27K	Hold	20,000	–	–	0.01%	158
2015 Q4	$34K	Hold	20,000	–	–	0.01%	175
2015 Q3	$31K	Hold	20,000	–	–	0.01%	188
2015 Q2	$54K	Hold	20,000	–	–	0.01%	181
2015 Q1	$138K	Hold	20,000	–	–	0.04%	171
2014 Q4	$197K	Hold	20,000	–	–	0.08%	134
2014 Q3	$137K	Buy	+20,000	New	+$123K	0.06%	143

Other funds holding CBAY

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return